Search results
Sarepta stock soars on Duchenne gene therapy expanded approval - Boston Business Journal
The Business Journals· 4 days agoShares of Sarepta Therapeutics shot up nearly 35% when markets opened Friday, following the FDA's...
Shares of Sarepta Therapeutics shot up nearly 35% when markets opened Friday, following the FDA's...